The objective of this study is two fold, first to explore the potential of context sensitive intervention delivery to provide in-situ support for people with depressive symptoms, second to explore the detection of daily-life behavior based on smart phone sensor information to identify subjects with a clinically meaningful depression level.
To conduct a very first pilot trial, a monocentric, single-arm clinical study is conducted. The study is approved by the local ethics committee of the Canton of Zurich in Switzerland and the Swiss Agency for Therapeutic Products. It is conducted in full accordance with the Declaration of Helsinki, with all subjects providing their electronic informed consent prior to participation. As the main interest lies in a proof of concept of the proposed MOSS app, emphasis is put on real life conditions. A range of different recruitment channels is used to attract subjects from the general public; they include physical flyers, online posts on relevant online bulletin boards and the Google Play Store.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
126
Patient Health Questionnaire - for depression (PHQ-9)
subjective depressive symptoms to compare the detected symptoms measured by the app This outcome is needed for the sensing part of the study
Time frame: baseline
Client Satisfaction Questionnaire (ZUF-8)- measures client satisfaction with the app
Client satisfaction with the app is assessed
Time frame: at post (at least 6 weeks after baseline) however some participants will use the app longer than 6 weeks, maximum 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.